Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Gillespie

Showing results (211-220 of 264) with videos related to

Pageof 27
Sort By:
Bone|July 28, 1999
Calcitonin receptor antibodies in the identification of osteoclastsJ M Quinn, M Morfis, M H Lam, et al.
Bone|January 24, 2016
Deferasirox at therapeutic doses is associated with dose-dependent hypercalciuriaPhillip Wong, Kevan Polkinghorne, Peter G Kerr, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2008
IL-23 inhibits osteoclastogenesis indirectly through lymphocytes and is required for the maintenance of bone mass in miceJulian M W Quinn, Natalie A Sims, Hasnawati Saleh, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 1988
Multiresistant Staphylococcus aureus: genetics and evolution of epidemic Australian strainsR A Skurray, D A Rouch, B R Lyon, et al.
Endocrinology|August 31, 2000
Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and functionN Udagawa, N Takahashi, H Yasuda, et al.
Endocrinology|March 10, 1998
Osteoclasts from human giant cell tumors of bone lack estrogen receptorsF M Collier, W H Huang, W R Holloway, et al.
Molecular and Cellular Endocrinology|December 3, 2014
Osteoclast formation elicited by interleukin-33 stimulation is dependent upon the type of osteoclast progenitorDamien G Eeles, Jason M Hodge, Preetinder P Singh, et al.
JTCVS Techniques|February 1, 2021
Coronavirus disease 2019 (COVID-19): Team preparation and approach to tracheostomyAlejandro C Bribriesco, Monisha Sudarshan, Colin T Gillespie, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 7, 1998
Detection of K-ras mutations in resected primary leiomyosarcomaM A Hill, C Gong, T J Casey, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1996
Identification of the human cytochromes P450 responsible for the in vitro formation of the major oxidative metabolites of the antipsychotic agent olanzapineB J Ring, J Catlow, T J Lindsay, et al.
Pageof 27

Showing results (211-220 of 264) with videos related to

Sort By:
Pageof 27
Bone|July 28, 1999
Calcitonin receptor antibodies in the identification of osteoclastsJ M Quinn, M Morfis, M H Lam, et al.
Bone|January 24, 2016
Deferasirox at therapeutic doses is associated with dose-dependent hypercalciuriaPhillip Wong, Kevan Polkinghorne, Peter G Kerr, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2008
IL-23 inhibits osteoclastogenesis indirectly through lymphocytes and is required for the maintenance of bone mass in miceJulian M W Quinn, Natalie A Sims, Hasnawati Saleh, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 1988
Multiresistant Staphylococcus aureus: genetics and evolution of epidemic Australian strainsR A Skurray, D A Rouch, B R Lyon, et al.
Endocrinology|August 31, 2000
Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and functionN Udagawa, N Takahashi, H Yasuda, et al.
Endocrinology|March 10, 1998
Osteoclasts from human giant cell tumors of bone lack estrogen receptorsF M Collier, W H Huang, W R Holloway, et al.
Molecular and Cellular Endocrinology|December 3, 2014
Osteoclast formation elicited by interleukin-33 stimulation is dependent upon the type of osteoclast progenitorDamien G Eeles, Jason M Hodge, Preetinder P Singh, et al.
JTCVS Techniques|February 1, 2021
Coronavirus disease 2019 (COVID-19): Team preparation and approach to tracheostomyAlejandro C Bribriesco, Monisha Sudarshan, Colin T Gillespie, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 7, 1998
Detection of K-ras mutations in resected primary leiomyosarcomaM A Hill, C Gong, T J Casey, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1996
Identification of the human cytochromes P450 responsible for the in vitro formation of the major oxidative metabolites of the antipsychotic agent olanzapineB J Ring, J Catlow, T J Lindsay, et al.
Pageof 27